Imexpharm Corp
VN:IMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nordea Bank Abp
OMXH:NDA FI
|
FI |
Imexpharm Corp
Other Long-Term Assets
Imexpharm Corp
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Imexpharm Corp
VN:IMP
|
Other Long-Term Assets
₫388.8B
|
CAGR 3-Years
128%
|
CAGR 5-Years
60%
|
CAGR 10-Years
15%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Other Long-Term Assets
₫6.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
15%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Other Long-Term Assets
₫17.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Other Long-Term Assets
₫3.4B
|
CAGR 3-Years
54%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-11%
|
|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Other Long-Term Assets
₫58B
|
CAGR 3-Years
5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Other Long-Term Assets
₫88B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
35%
|
|
Imexpharm Corp
Glance View
Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
See Also
What is Imexpharm Corp's Other Long-Term Assets?
Other Long-Term Assets
388.8B
VND
Based on the financial report for Dec 31, 2025, Imexpharm Corp's Other Long-Term Assets amounts to 388.8B VND.
What is Imexpharm Corp's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
15%
Over the last year, the Other Long-Term Assets growth was 214%. The average annual Other Long-Term Assets growth rates for Imexpharm Corp have been 128% over the past three years , 60% over the past five years , and 15% over the past ten years .
